Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-14 Purchase |
2020-10-16 3:51 pm |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
75,800 | $19 | $1,440,200 | 1,952,364 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-03 Option Award |
2021-03-05 8:04 pm |
2022-03-03 2031-03-03 |
Sarepta Therapeutics Inc. | SRPT | MARTIN JOHN C Director |
8,244 | $0 | 13,431 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:51 pm |
N/A N/A |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
6,570,443 | $0 | 1,952,364 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:51 pm |
N/A N/A |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
205,260 | $16.15 | 1,952,364 (Indirect) |
View |
Ownership |
2020-10-08 7:11 pm |
N/A N/A |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
0 | $0 | 1,876,564 (Direct) |
View |